Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX-NEURO Trial
NCT07398066Not yet recruiting
- Sponsor
- Universiti Malaya
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain and postoperative delirium (POD) (2 arms), sponsored by Universiti Malaya. Primary endpoint: Postoperative pain score at 2 days. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on NCT07398066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398066.